Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 12/20 | 0.59 |
| ▸ | PRSS1 | P07477 | 5/20 | 0.47 |
| ▸ | F10 | P00742 | 2/20 | 0.47 |
| ▸ | PLG | P00747 | 2/20 | 0.47 |
| ▸ | TMPRSS11D | O60235 | 4/20 | 0.46 |
| ▸ | STS | P08842 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9076770 | 1.00 | F2 (0.59) | F2PRSS1F10PLGTMPRSS11D | |
| SCHEMBL7306031 | 0.85 | TMPRSS11D (0.54) | F2PRSS1F10PLGTMPRSS11D | |
| SCHEMBL7305864 | 0.85 | TMPRSS11D (0.54) | F2PRSS1F10PLGTMPRSS11D | |
| SCHEMBL9074726 | 0.83 | F2 (0.62) | F2PRSS1F10PLG | |
| SCHEMBL9074718 | 0.83 | F2 (0.62) | F2PRSS1F10PLG | |
| SCHEMBL22191887 | 0.75 | F2 (1.00) | F2F10 | |
| SCHEMBL7341151 | 0.74 | TMPRSS11D (0.57) | F2PRSS1F10PLGTMPRSS11D | |
| SCHEMBL10404674 | 0.74 | ACE (0.61) | — | |
| SCHEMBL10058307 | 0.74 | ACE (0.61) | — | |
| SCHEMBL9076780 | 0.74 | F2 (1.00) | F2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5583146-A | Heterocyclic thrombin inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-10 | — | — | US | disclosed |
| EP-0623596-A1 | N-acylpyrrolidines or N-acylpiperidines having a guanidinyl- or amidinyl-substituted side chain as thrombin inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-11-09 | — | — | EP | disclosed |